Ampersand Capital Partners acquires Specac, Ltd.

Ampersand Capital Partners announced the acquisition of Specac Limited.

“On behalf of the entire Specac organization, we are excited to partner with the Ampersand team and join its diverse portfolio of companies. Ampersand’s extensive experience and network within the life sciences technology space will position Specac to continue its growth trajectory and build upon our strong OEM customer relationships across the globe,” says Shannon Postma, Managing Director of Specac.

Specac employs around 80 people with offices in the US and UK, supported by a global network of distributors and dealers.

David Patteson, Partner at Ampersand, adds, “We are thrilled to partner with the entire Specac team. Ampersand’s expertise in accelerating growth-minded life sciences-oriented lab products organizations make them an excellent fit. Under Shannon’s leadership, Specac is poised for continued success delivering customer-focused solutions, exceptional quality, and superior service via its talented specialists.”
MB Bureau